Janus Henderson

Portfolio Companies 2026 for Janus Henderson: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Janus Henderson accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $2.3B. The median disclosed raise is $357M, and the largest is Edgewise Therapeutics at $495M, ahead of T-knife ($383M) and Mister Spex ($375M).

The names that recur most often on these portfolio cap tables are Janus Henderson (8 companies), RA Capital (3 companies), Cormorant Asset Management (2 companies), OrbiMed (1 company), Novo Holdings (1 company), Viking Global (1 company). By latest disclosed round, the market skews IPO (2), Series D (2), Growth (1), Series F (1).

Companies tracked: 8
Disclosed funding total: $2.3B across 8 companies
Median disclosed raise: $357M
Largest raise: Edgewise Therapeutics — $495M
Stage mix: IPO 2 · Series D 2 · Growth 1 · Series F 1
Most recent dated round: 2026-06-01

Best funded Janus Henderson companies

Edgewise Therapeutics — $495M (latest: Growth)
T-knife — $383M (latest: Series F)
Mister Spex — $375M (latest: IPO)
Circle — $357M
Ollin Biosciences — $330M (latest: Series B)
Apartment List — $150M (latest: Series D)
Wave Life Sciences — $102M (latest: IPO)
BioAtla — $73M (latest: Series D)

Janus Henderson Emerging Markets Private Investments Limited — related firms and companies (56)

Janus Henderson Emerging Markets Private Investments Limited profile · All research reports